Literature DB >> 23526211

Inhibition of complement activation alleviates acute lung injury induced by highly pathogenic avian influenza H5N1 virus infection.

Shihui Sun1, Guangyu Zhao, Chenfeng Liu, Xiaohong Wu, Yan Guo, Hong Yu, Hongbin Song, Lanying Du, Shibo Jiang, Renfeng Guo, Stephen Tomlinson, Yusen Zhou.   

Abstract

The acute lung injury (ALI) that occurs after the highly pathogenic avian influenza H5N1 virus infection is associated with an abnormal host innate immune response. Because the complement system plays a central role in innate immunity and because aberrant complement activation is associated with a variety of autoimmune and inflammatory diseases, we investigated the complement involvement in the pathogenesis of ALI induced by H5N1 virus infection. We showed that ALI in H5N1-infected mice was caused by excessive complement activation, as demonstrated by deposition of C3, C5b-9, and mannose-binding lectin (MBL)-C in lung tissue, and by up-regulation of MBL-associated serine protease-2 and the complement receptors C3aR and C5aR. Treatment of H5N1-infected mice with a C3aR antagonist led to significantly reduced inflammation in lungs, alleviating ALI. Furthermore, complement inhibition with an anti-C5a antibody or complement depletion with cobra venom factor after H5N1 challenge resulted in a similar level of protection to that seen in C3aR antagonist-treated mice. These results indicate that excessive complement activation plays an important role in mediating H5N1-induced ALI and that inhibition of complement may be an effective clinical intervention and adjunctive treatment for H5N1-induced ALI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23526211     DOI: 10.1165/rcmb.2012-0428OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  55 in total

1.  Effects of mannose-binding lectin on pulmonary gene expression and innate immune inflammatory response to ozone.

Authors:  Jonathan M Ciencewicki; Kirsten C Verhein; Kevin Gerrish; Zachary R McCaw; Jianying Li; Pierre R Bushel; Steven R Kleeberger
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-04-22       Impact factor: 5.464

Review 2.  Viral-derived complement inhibitors: current status and potential role in immunomodulation.

Authors:  Hadi Abou-El-Hassan; Hassan Zaraket
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-26

Review 3.  The inflammatory response triggered by Influenza virus: a two edged sword.

Authors:  Luciana P Tavares; Mauro M Teixeira; Cristiana C Garcia
Journal:  Inflamm Res       Date:  2016-10-15       Impact factor: 4.575

4.  iTRAQ-based quantitative proteomics reveals important host factors involved in the high pathogenicity of the H5N1 avian influenza virus in mice.

Authors:  Jiao Hu; Zhao Gao; Xiaoquan Wang; Min Gu; Yanyan Liang; Xiaowen Liu; Shunlin Hu; Huimou Liu; Wenbo Liu; Sujuan Chen; Daxin Peng; Xiufan Liu
Journal:  Med Microbiol Immunol       Date:  2016-12-20       Impact factor: 3.402

5.  Donor pretreatment with nebulized complement C3a receptor antagonist mitigates brain-death induced immunological injury post-lung transplant.

Authors:  Qi Cheng; Kunal Patel; Biao Lei; Lindsay Rucker; D Patterson Allen; Peng Zhu; Chentha Vasu; Paulo N Martins; Martin Goddard; Satish N Nadig; Carl Atkinson
Journal:  Am J Transplant       Date:  2018-04-10       Impact factor: 8.086

Review 6.  Sepsis and septic shock.

Authors:  Richard S Hotchkiss; Lyle L Moldawer; Steven M Opal; Konrad Reinhart; Isaiah R Turnbull; Jean-Louis Vincent
Journal:  Nat Rev Dis Primers       Date:  2016-06-30       Impact factor: 52.329

7.  Polysaccharides from Arnebia euchroma Ameliorated Endotoxic Fever and Acute Lung Injury in Rats Through Inhibiting Complement System.

Authors:  Ying-Ye Ou; Yun Jiang; Hong Li; Yun-Yi Zhang; Yan Lu; Dao-Feng Chen
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

Review 8.  Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection.

Authors:  A P Hakansson; C J Orihuela; D Bogaert
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 9.  Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation.

Authors:  Isabelle Amigues; Alexander H Pearlman; Aarat Patel; Pankti Reid; Philip C Robinson; Rashmi Sinha; Alfred Hj Kim; Taryn Youngstein; Arundathi Jayatilleke; Maximilian Konig
Journal:  Expert Rev Clin Immunol       Date:  2020-11-25       Impact factor: 4.473

10.  SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation.

Authors:  Bingyu Yan; Tilo Freiwald; Daniel Chauss; Luopin Wang; Erin West; Claudia Kemper; Behdad Afzali; Majid Kazemian; Carmen Mirabelli; Charles J Zhang; Eva-Maria Nichols; Nazish Malik; Richard Gregory; Marcus Bantscheff; Sonja Ghidelli-Disse; Martin Kolev; Tristan Frum; Jason R Spence; Jonathan Z Sexton; Konstantinos D Alysandratos; Darrell N Kotton; Stefania Pittaluga; Jack Bibby; Nathalie Niyonzima; Matthew R Olson; Shahram Kordasti; Didier Portilla; Christiane E Wobus; Arian Laurence; Michail S Lionakis
Journal:  Sci Immunol       Date:  2021-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.